http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018058909-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate | 2018-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8e9aa9c037306f6e876e0ead0719b68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c37c5a8ac7de27babf9c4e45845d43 |
| publicationDate | 2018-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018058909-A |
| titleOfInvention | Pharmaceutical composition for oral administration |
| abstract | The present invention relates to a pharmaceutical tablet containing minodronic acid or a pharmaceutically acceptable salt or hydrate thereof useful as a therapeutic agent for osteoporosis, which has improved drug dissolution, tablet hardness, wrinkle adhesion and the like. A dosage formulation is provided. The pharmaceutical tablet comprises 50 mg or 60 mg of minodronic acid or a pharmaceutically acceptable salt or hydrate thereof in the pharmaceutical tablet, and croscarmellose sodium, crospovidone, and carboxymethyl starch sodium. 1 or two or more substances selected from the group consisting of: Minodronic acid or a pharmaceutically acceptable salt thereof or a hydrate thereof was measured by a laser diffraction method described in Japanese Pharmacopoeia The average particle diameter D 50 is 1 μm or more and 20 μm or less, and the drug dissolution rate 15 minutes after the start of the dissolution test is 80% or more. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112972400-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022131844-A1 |
| priorityDate | 2011-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.